Bioactive and resorbable synthetic bone graft substitute designed to resemble human bone. It is composed of hydroxyapatite and beta tricalcium phosphate.
Abonia is characterized by its unique MBCP® Micro and Macroporous Biphasic Calcium Phosphate technology, composed of 60% hydroxyapatite (HA) and 40% beta tricalcium phosphate (β-TCP) which allows for the biological exchanges necessary for bone ingrowth and mineralization.1.
Characteristics of MBCP® Technology
- 300 600 µm macropores
Interconnected spaces that promote biological infiltration and cell colonization by osteoblasts and osteoclasts leading to osteoconduction.2
- Micropores <10 µm
Crystalline spaces in which dissolution and precipitation of new biological apatite crystals occur leading to osteogenic properties with scaffold permeability.3
- Global porosity of 70%
The interconnected network of macro- and micropores providing 70% porosity, similar to that of cancellous bone.
Benefits:
Reproducible and homogeneous
Gradually absorbed while maintaining its density
Achieves the natural process of angiogenesis and osteogenesis
Resorption similar to human bone.
Osteogenic properties that adapt to the host bone
Elimination of biohazard
100% regeneration of Havers bone
Adaptability for tissue engineering
Indications:
- Filling of bone cavities
- Bone graft extender
- Filling, augmenting or reconstructing bone defects
Dental:
- Sinus lift
- Extraction site
- Periodontal defect
- Ridge augmentation
Trauma – Orthopedics
- Hip revision
- Long bone fracture
- Cystic tumor
Spine Surgery:
- Spinal fusion 4
- Posterolateral fusion
Knee:
- Tibial fracture
Presentations:
0.25 cc -0.5 cc - 1 cc - 2 cc - 5 cc
10 cc -16 cc - 20 cc - 30 cc
0.5 mL - 1 mL - 2.5 mL
5 mL - 10 mL
Bibliographic references:
- García-Garduño, Margarita Victoria, & Reyes-Gasga, José. (2006). La hidroxiapatita, su importancia en los tejidos mineralizados y su aplicación biomédica. TIP. Revista especializada en ciencias químico-biológicas, 9(2), 90-95. Recuperado en 14 de diciembre de 2020, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1405-888X2006000200090&lng=es&tlng=es.
- Daculsi (1999). Cinética de sustitución ósea esponjosa y cortical a expensas del fosfato de calcio bifásico macroporoso: evidencia animal y humana. Bioceramics
- Legeros (1988). Importancia de la porosidad y la química física de la biodegradación-bioregradación de la cerámica de fosfato de calcio biodegradación.
- Daculsi (2013). Estudios clínicos de fusión cervical anterior con jaulas de PEEK: comparación de injerto ilíaco y un fosfato de calcio bifásico macroporoso.
Information:
Phone: + 601 616 0255
info@avalon.com.co
About Avalon
Website Map